VERTEX PHARMACEUTICALS INC / MA Accumulated OCI 2009-2026 | VRTX
Beta
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is VERTEX PHARMACEUTICALS INC / MA's current accumulated oci?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual accumulated oci for 2025 was $-15.9M, a 112.44% decline from 2024. VERTEX PHARMACEUTICALS INC / MA accumulated oci for the quarter ending March 31, 2026 was $24.8M.
What was VERTEX PHARMACEUTICALS INC / MA's accumulated oci in 2024?
VERTEX PHARMACEUTICALS INC / MA annual accumulated oci for 2024 was $127.8M, a 993.71% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's accumulated oci in 2023?
VERTEX PHARMACEUTICALS INC / MA annual accumulated oci for 2023 was $-14.3M, a 1887.50% decline from 2022.
Accumulated OCI History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-68.5M
→
FY2025
$-15.9M
0910111213141516171819202122232425
5 years selected
Accumulated OCI History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-15.9M | -112.4% | 10-K |
| FY2024 | $127.8M | +993.7% | 10-K |
| FY2023 | $-14.3M | -1887.5% | 10-K |
| FY2022 | $800,000 | -95.0% | 10-K |
| FY2021 | $15.9M | +123.2% | 10-K |
| FY2020 | $-68.5M | -3371.9% | 10-K |
| FY2019 | $-2.0M | -399.4% | 10-K |
| FY2018 | $659,000 | +105.7% | 10-K |
| FY2017 | $-11.6M | -154.7% | 10-K |
| FY2016 | $21.2M | +1060.8% | 10-K |
| FY2015 | $1.8M | +98.9% | 10-K |
| FY2014 | $917,000 | +399.7% | 10-K |
| FY2013 | $-306,000 | +44.4% | 10-K |
| FY2012 | $-550,000 | +47.8% | 10-K |
| FY2011 | $-1.1M | +1.3% | 10-K |
| FY2010 | $-1.1M | -66.7% | 10-K |
| FY2009 | $-640,000 | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →